Qube Research & Technologies Ltd - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$234,767
-88.8%
10,476
-74.8%
0.00%
-91.7%
Q3 2022$2,091,000
+237.8%
41,654
+218.8%
0.01%
+20.0%
Q1 2021$619,000
+14.8%
13,066
+47.8%
0.01%
+25.0%
Q4 2020$539,000
+87.2%
8,839
+47.3%
0.01%
-11.1%
Q4 2019$288,0006,0000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders